Explores C sp2–C sp3 bond formation in bioisosteres, suggesting new chemical methodologies.
Using the inexpensive, air-stable ruthenium catalyst derived from RuHCl(CO)(PPh 3 ) 3 and the achiral ligands Cy-BIPHEP or dCypb, acetylenic bicyclooctyl, azabicycloheptyl, adamantyl, bicyclopentyl and azabicyclooctyl bioisosteres 2a – 2f are conjugated to diverse azines and azoles 1a – 1t via C sp 2 –C sp 3 bond formation. Using chiral ruthenium catalysts modified by ( S )-Cy-SEGPHOS or ( R )-Cy-BINAP, high levels of enantioselectivity are obtained in reactions of azines. Late-stage C–H functionalization of the B(Epin) derivative of bortezomib (Velcade) and studies corroborating the reaction mechanism are described.
No takes yet. Share an insight, caveat, or question.
Teoh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: